Notably, we also identified, metabolic fibroblasts, previously described in scRNA-seq analysis of pancreatic ductal adenocarcinoma, characterized by elevated expression of marker gene PLA2G2A (63). The gene discussed is PLA2G2A; the disease is pancreatic ductal adenocarcinoma.